Search

Stephen F. Husar

Examiner (ID: 168, Phone: (571)272-2371 , Office: P/2875 )

Most Active Art Unit
2875
Art Unit(s)
3406, 2605, 2875, 2899, 3401
Total Applications
3540
Issued Applications
3164
Pending Applications
83
Abandoned Applications
295

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19738285 [patent_doc_number] => 12215103 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-02-04 [patent_title] => Fused imidazole derivative, preparation method therefor, and medical use thereof [patent_app_type] => utility [patent_app_number] => 18/612631 [patent_app_country] => US [patent_app_date] => 2024-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33767 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18612631 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/612631
Fused imidazole derivative, preparation method therefor, and medical use thereof Mar 20, 2024 Issued
Array ( [id] => 19738285 [patent_doc_number] => 12215103 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-02-04 [patent_title] => Fused imidazole derivative, preparation method therefor, and medical use thereof [patent_app_type] => utility [patent_app_number] => 18/612631 [patent_app_country] => US [patent_app_date] => 2024-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33767 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18612631 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/612631
Fused imidazole derivative, preparation method therefor, and medical use thereof Mar 20, 2024 Issued
Array ( [id] => 19738285 [patent_doc_number] => 12215103 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-02-04 [patent_title] => Fused imidazole derivative, preparation method therefor, and medical use thereof [patent_app_type] => utility [patent_app_number] => 18/612631 [patent_app_country] => US [patent_app_date] => 2024-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33767 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18612631 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/612631
Fused imidazole derivative, preparation method therefor, and medical use thereof Mar 20, 2024 Issued
Array ( [id] => 19497610 [patent_doc_number] => 20240336628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-10 [patent_title] => NOVEL COMPOUNDS, COMPOSITIONS, AND THERAPEUTIC USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/600347 [patent_app_country] => US [patent_app_date] => 2024-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51342 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18600347 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/600347
NOVEL COMPOUNDS, COMPOSITIONS, AND THERAPEUTIC USES THEREOF Mar 7, 2024 Abandoned
Array ( [id] => 19579849 [patent_doc_number] => 12145945 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-11-19 [patent_title] => Compounds, compositions, and therapeutic uses thereof [patent_app_type] => utility [patent_app_number] => 18/600352 [patent_app_country] => US [patent_app_date] => 2024-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51138 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18600352 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/600352
Compounds, compositions, and therapeutic uses thereof Mar 7, 2024 Issued
Array ( [id] => 19528104 [patent_doc_number] => 20240352006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-24 [patent_title] => METHODS OF MANUFACTURE AND SYNTHESIS OF FLUORESCENT DYE COMPOUNDS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/596703 [patent_app_country] => US [patent_app_date] => 2024-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6558 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18596703 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/596703
METHODS OF MANUFACTURE AND SYNTHESIS OF FLUORESCENT DYE COMPOUNDS AND USES THEREOF Mar 5, 2024 Pending
Array ( [id] => 19354050 [patent_doc_number] => 12054479 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-08-06 [patent_title] => Multicyclic compounds [patent_app_type] => utility [patent_app_number] => 18/596024 [patent_app_country] => US [patent_app_date] => 2024-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19398 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18596024 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/596024
Multicyclic compounds Mar 4, 2024 Issued
Array ( [id] => 19800463 [patent_doc_number] => 20250066388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-27 [patent_title] => 1,3,4,7-TETRAHYDRO-2H-PYRROLO[3',2':5,6]PYRIDO[2,3-B][1,4]OXAZEPINE BCL-2 INHIBITORS [patent_app_type] => utility [patent_app_number] => 18/595898 [patent_app_country] => US [patent_app_date] => 2024-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47195 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18595898 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/595898
1,3,4,7-TETRAHYDRO-2H-PYRROLO[3',2':5,6]PYRIDO[2,3-B][1,4]OXAZEPINE BCL-2 INHIBITORS Mar 4, 2024 Abandoned
Array ( [id] => 19543120 [patent_doc_number] => 20240360156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-31 [patent_title] => HETEROCYCLIC COMPOUND AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/592897 [patent_app_country] => US [patent_app_date] => 2024-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 85092 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -35 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18592897 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/592897
HETEROCYCLIC COMPOUND AND USE THEREOF Feb 29, 2024 Pending
Array ( [id] => 19397086 [patent_doc_number] => 12071428 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-08-27 [patent_title] => Indazole compounds as kinase inhibitors [patent_app_type] => utility [patent_app_number] => 18/584440 [patent_app_country] => US [patent_app_date] => 2024-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 89836 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18584440 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/584440
Indazole compounds as kinase inhibitors Feb 21, 2024 Issued
Array ( [id] => 19380887 [patent_doc_number] => 20240270757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-15 [patent_title] => SPIROCYCLIC COMPOUNDS [patent_app_type] => utility [patent_app_number] => 18/443829 [patent_app_country] => US [patent_app_date] => 2024-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30642 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18443829 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/443829
SPIROCYCLIC COMPOUNDS Feb 15, 2024 Pending
Array ( [id] => 19389349 [patent_doc_number] => 20240279219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-22 [patent_title] => COMPOUNDS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 18/430429 [patent_app_country] => US [patent_app_date] => 2024-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 469745 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18430429 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/430429
Compounds and methods of use Jan 31, 2024 Issued
Array ( [id] => 19871310 [patent_doc_number] => 12264154 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-04-01 [patent_title] => Compounds and methods of use [patent_app_type] => utility [patent_app_number] => 18/430456 [patent_app_country] => US [patent_app_date] => 2024-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 481528 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18430456 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/430456
Compounds and methods of use Jan 31, 2024 Issued
Array ( [id] => 19248606 [patent_doc_number] => 20240199593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-20 [patent_title] => Novel Heteroaryl Aminopropanol Derivatives [patent_app_type] => utility [patent_app_number] => 18/426461 [patent_app_country] => US [patent_app_date] => 2024-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43874 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18426461 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/426461
Novel Heteroaryl Aminopropanol Derivatives Jan 29, 2024 Pending
Array ( [id] => 19380846 [patent_doc_number] => 20240270716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-15 [patent_title] => PIPERIDINE DERIVATIVES AS METTL3 INHIBITORS [patent_app_type] => utility [patent_app_number] => 18/417159 [patent_app_country] => US [patent_app_date] => 2024-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 156010 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18417159 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/417159
Piperidine derivatives as METTL3 inhibitors Jan 18, 2024 Issued
Array ( [id] => 19554827 [patent_doc_number] => 20240366619 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-07 [patent_title] => NON-CATALYTIC SUBSTRATE-SELECTIVE p38alpha-SPECIFIC MAPK INHIBITORS WITH ENDOTHELIAL-STABILIZING AND ANTI-INFLAMMATORY ACTIVITY, AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/416532 [patent_app_country] => US [patent_app_date] => 2024-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44880 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18416532 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/416532
NON-CATALYTIC SUBSTRATE-SELECTIVE p38alpha-SPECIFIC MAPK INHIBITORS WITH ENDOTHELIAL-STABILIZING AND ANTI-INFLAMMATORY ACTIVITY, AND METHODS OF USE THEREOF Jan 17, 2024 Pending
Array ( [id] => 19651233 [patent_doc_number] => 12173001 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-12-24 [patent_title] => Pyrido[3,4-e][1,2,4]triazolo[4,3-c]pyrimidines as CK2 inhibitors [patent_app_type] => utility [patent_app_number] => 18/413744 [patent_app_country] => US [patent_app_date] => 2024-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9442 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18413744 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/413744
Pyrido[3,4-e][1,2,4]triazolo[4,3-c]pyrimidines as CK2 inhibitors Jan 15, 2024 Issued
Array ( [id] => 19754356 [patent_doc_number] => 20250042921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-06 [patent_title] => KRAS MODULATORS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/413444 [patent_app_country] => US [patent_app_date] => 2024-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 69698 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18413444 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/413444
KRAS MODULATORS AND USES THEREOF Jan 15, 2024 Pending
Array ( [id] => 19738283 [patent_doc_number] => 12215101 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-02-04 [patent_title] => Pro drugs of PDE10 compounds [patent_app_type] => utility [patent_app_number] => 18/538309 [patent_app_country] => US [patent_app_date] => 2023-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14004 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18538309 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/538309
Pro drugs of PDE10 compounds Dec 12, 2023 Issued
Array ( [id] => 19096353 [patent_doc_number] => 20240115580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-11 [patent_title] => METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS [patent_app_type] => utility [patent_app_number] => 18/533515 [patent_app_country] => US [patent_app_date] => 2023-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23687 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18533515 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/533515
METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS Dec 7, 2023 Abandoned
Menu